Compare VKTX & MIAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VKTX | MIAX |
|---|---|---|
| Founded | 2012 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.8B |
| IPO Year | 2015 | 2025 |
| Metric | VKTX | MIAX |
|---|---|---|
| Price | $34.04 | $43.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 6 |
| Target Price | ★ $87.07 | $47.20 |
| AVG Volume (30 Days) | ★ 3.3M | 1.2M |
| Earning Date | 02-04-2026 | 02-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,318,535,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 22.86 |
| 52 Week Low | $18.92 | $28.63 |
| 52 Week High | $43.15 | $51.38 |
| Indicator | VKTX | MIAX |
|---|---|---|
| Relative Strength Index (RSI) | 49.82 | N/A |
| Support Level | $29.54 | N/A |
| Resistance Level | $36.00 | N/A |
| Average True Range (ATR) | 1.98 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 59.83 | 0.00 |
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Miami International Holdings Inc is a technology-driven leader in building and operating regulated financial marketplaces across multiple asset classes and geographies. Its MIAX Exchange marketplaces are enabled by its in-house built, proprietary technology. It maintains a broad portfolio of U.S. exchange and clearing licenses, in both securities and futures. The company operates markets across a diverse number of asset classes including options and cash equities as well as futures and options on futures.